Back to search

Ireland· IE-PA-PA2261/007/001

Bisodol Antacid Chewable Tablets Calcium Carbonate 522mg Magnesium Carbonate Light 68mg Sodium Hydrogen Carbonate 64mg

A calcium carbonate product containing sodium hydrogen carbonate + calcium carbonate + light magnesium carbonate, registered in Ireland by Dexcel Pharma GmbH. The same ATC class is registered in 7 of our 19 countries.

ATC A02AC01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedBisodol Antacid Chewable Tablets Calc…ATCA02AC01REGISTER NO.IE-PA-PA2261/007/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Calcium carbonate is registered in 7 of 19 countries.

Countries holding a registration under ATC A02AC01 (calcium carbonate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Calcium carbonate · ATC A02AC01

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Sodium hydrogen carbonate + Calcium carbonate + Light magnesium carbonate
Manufacturer
Dexcel Pharma GmbH
Country
Ireland (IE)
ATC code
A02AC01
ATC class
Calcium carbonate
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2261/007/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

225 interactions on record for calcium carbonate.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Calcium carbonate · interactions on record

225 records

  • 8 severe
  • 153 moderate
  • 64 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • DolutegravirJ05AJ03severe
  • RaltegravirJ05AX08severe
  • DolutegravirJ05AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/13c114f8-b222-4798-8bf3-46ebfe4a2bdf
GET /v1/drugs/13c114f8-b222-4798-8bf3-46ebfe4a2bdf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Chewable tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A02AC",
    "A02AC01"
  ],
  "strength": null,
  "pa_number": "PA2261/007/001",
  "substances": [
    "Sodium hydrogen carbonate",
    "Calcium carbonate",
    "Light magnesium carbonate"
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1983",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through non-pharmacy outlets and pharmacies",
  "interchangeable_code": null
}

See everything about calcium carbonate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.